Essential medicines and health products

Country and regional medicines projects

WHO coordinates projects that support countries to develop, implement, and monitor national policies and practices and strengthen pharmaceutical systems. The goal: to ensure that high quality essential medicines are available, affordable and used appropriately. We help countries set and agree their medicines priorities, draw up and implement plans, and monitor and evaluate them. We encourage collaboration between countries to improve quality, selection and use, and to increase availability and affordability of medicines. We promote transparency and good governance, and advocate a coordinated, multi-stakeholder approach that involves the private sector, civil society, academic and other partners.

The EU/ACP/WHO Renewed Partnership

The EU/ACP/WHO Renewed Partnership aims to strengthen pharmaceutical systems and improve access to quality medicines in African ACP (Africa, Caribbean and Pacific) countries. The project is the follow-up of a 6 years’ collaboration with the EC on the EC/ACP/WHO Partnership on Pharmaceutical Policies which was finalized in 2010. The first partnership has been instrumental to support ACP countries to generate reliable medicines information, to develop and endorse policies, regulations and best practices and to strengthen capacity of the pharmaceutical sector. The renewed Partnership will build on this momentum, focusing on the implementation of national medicines policies, regulations and practices. The Renewed Partnership will reinforce collaboration and synergy with Regional Economic Communities and other partners' initiatives, for improving access to and use of quality assured medicines.

Good Governance for Medicines

The Good Governance for Medicines programme aims to contribute to health systems strengthening by promoting good governance in the pharmaceutical sector. 36 countries and territories have participated in the programme since its inception in 2004.

Medicines Transparency Alliance Initiative

The MeTA initiative aims to improve access to quality-assured essential medicines in low-income countries through a multi-stakeholder collaboration involving representatives of the public sector, the private sector and civil society. Participating countries include Ghana, Jordan, Kyrgyzstan, Peru, the Philippines, Uganda and Zambia.



Dr. Gilles Forte
Team Coordinator
Medicines Policy, Governance, Information and Coordination
Department of Essential Medicines and Health Products
Avenue Appia 20 27 Geneva- CH-1211 Switzerland
+41 22 791 36 17